Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
Joan T. Merrill, William R Shanahan, Morton Aaron Scheinberg, KENNETH C. KALUNIAN, David Wofsy, Renée S. Martin
- Rank
- 46 of 1,672
- Percentile
- top 2.8%
- Where
- Annals of the Rheumatic Diseases, 2018
- Citations
- 157
From the 2018 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.